Fundraising Fox
/Companies
Sign in

WonderTx

YC S26

San Francisco, US · 3 employees · 15 known investors

Find your way into WonderTx

Sign up to see every warm intro you have to WonderTx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the WonderTx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

WonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.

Also known as A Company in Stealth Mode Incorporated

AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryGenerative AIUnited States of AmericaAmerica / CanadaFully Remote

Founders & leadership· Y Combinator alumni (S26)

AHAbraham Heifets
Abraham HeifetsFounder · CEOAbraham Heifets is founder and CEO of WonderTx and previously co-founded Atomwise, an AI-driven drug discovery company. He earned a PhD from the University of Toronto, worked at IBM Research, is named on 15 patents and applications, and contributed AI work to Cornell's robotic soccer team.

Investors · 15

Transpose Platform Managementlisted by Transpose Platform ManagementSan Francisco

How we know: Transpose Platform Management's portfolio page · Y Combinator's founder network · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

0 ADreported

How we know: Y Combinator's founder network · Not right? Tell us

Alumni VenturesreportedManchester · $100K – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Blast.Clubreported$5.5M

How we know: Y Combinator's founder network · Not right? Tell us

Capitalize VCreportedChicago · $100K – $200K

How we know: Y Combinator's founder network · Not right? Tell us

Founder CapitalreportedSilicon Valley · $25K – $100K

How we know: Y Combinator's founder network · Not right? Tell us

Greater Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Maiora Rebel Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Metsu Capitalreported

How we know: Y Combinator's founder network · Not right? Tell us

Sequoia CapitalreportedMenlo Park · $100K – $50M

How we know: Y Combinator's founder network · Not right? Tell us

Singularity Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

Ventioneers CapitalreportedOakville

How we know: Y Combinator's founder network · Not right? Tell us

ZAKA VCreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

The YC application· Summer 2026 batch

Alumni Q&A

What is your long-term vision? If you truly succeed, what will be different about the world?
The founders aim to integrate AI throughout every stage of drug discovery, making the path from concept to clinic tractable for hard-to-treat diseases. Their intended outcome is longer, better lives for patients whose conditions currently cannot be drugged effectively.

Summarized from the founders' answers on their Y Combinator profile.

Related companies · 5

Output BiosciencesOutput builds generative AI models trained on biological data to discover and develop medicines. The company focuses on applying large biological models to improve diagnosis, treatment, and disease prevention.
Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
Reverie LabsReverie Labs develops cancer treatments designed to cross the blood-brain barrier and treat tumors in the central nervous system.
SFA TherapeuticsSFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.
Paceline BioPlay Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

Companies working in the same space as WonderTx.

Legal entities · 1

corporate structure
A Company in Stealth Mode Incorporated

Frequently asked questions

What does WonderTx do?
WonderTx is an AI-native biotech that develops extrapolative AI models to discover oral drug molecules for targets with validated human biology that currently lack a viable pill-based treatment. The company aims to convert injectable therapies into pills and works on both its own and partner drug discovery programs.
Who founded WonderTx?
WonderTx was founded by Abraham Heifets.
Who are WonderTx's investors?
WonderTx's investors include Pioneer, Transpose Platform Management, Y Combinator, 0 AD, Alumni Ventures, Blast.Club, Capitalize VC, Founder Capital and 7 more.
Where is WonderTx headquartered?
WonderTx is headquartered in San Francisco, US.